Pharmacology in the Elderly. Pharmacological Challenges in the Elderly  Pharmacokinetic changes  Pharmacodynamic changes  Multiple co-morbidities 

Slides:



Advertisements
Similar presentations
UGA Doctor of Pharmacy Candidate
Advertisements

Warfarin, Insulin and Digoxin are the most Dangerous drugs in the elderly. Do we believe that?
Connecting Pharmacology with Therapeutics Clive Roberts.
Pages 645 to 724 Mechanisms of Drug Interaction Pharmacokinetic –Reduced rate and/or completeness of absorption –Altered bioavailabilty –Reduced.
Prescribing in Disease Clive Roberts. So what are drugs good at treating (or preventing)? Pain Inflammation Infection Fluid retention Heart problems High.
Problems in Geriatric Pharmacotherapy
Drug Action Across the Life Span
Training for junior doctors and pharmacists
Principles of Drug Use in the Elderly Alastair Stephens Sophie Rozwadowski.
UMMS CRIT Module II: Pharmacist Case Review Abir O. Kanaan, PharmD Associate Professor of Pharmacy Practice Massachusetts College of Pharmacy and Health.
Polypharmacy in the Elderly
Copyright ©2010 by Pearson Education, Inc. Upper Saddle River, New Jersey All rights reserved. CHAPTER Gerontological Nursing, Second Edition Patricia.
Polypharmacy of Older Adults
Patterns of Prescription Drug Use among Older Adults Arlene S. Bierman, MD, MS Ontario Women’s Health Council Chair in Women’s Health Centre for Research.
Copyright © 2015 Cengage Learning® Chapter 27 Drugs and Older Adults.
UMMS CRIT Module II: Drug Therapy in the Elderly Jerry H. Gurwitz, MD Chief, Division of Geriatric Medicine University of Massachusetts Medical School.
CHAPTER 3 Life Span Considerations
Pharmacotherapy in the Elderly Paola S. Timiras May, 2007.
Pharmacotherapy in the Elderly Judy Wong
Dr AZZA ELSHERBINY Assistant professor of pharmacology.
Includes adults >65 years old Fastest growing population in US and in the majority of developed nations. 20% of hospitalizations for those >65 are due.
Yasar Kucukardali Professor, Internal Medicine Yeditepe University.
Drug safety in the elderly EFNS Stockholm 2012 Barbro Westerholm Prof.em, Member of Swedish Parliament.
Supported by DHHS/HRSA/BHPr/Division of Nursing Grant #D62HP06858 Best Nursing Practices in Care for Older Adults ELDER Project Fairfield University School.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 10 Drug Therapy in Pediatric Patients.
POLYPHARMACY Pio L. Oliverio, MD Fellow, Geriatrics SVCMC, Jamaica, NY
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 11 Drug Therapy in Geriatric Patients.
Food-Drug Interactions Chapter 19. © 2004, 2002 Elsevier Inc. All rights reserved. Key Terms n Bioavailability: degree to which a drug or other substance.
Objectives Describe the main physiological changes that occur with aging Identify factors affecting absorption and distribution with the geriatric client.
Dose Adjustment in Renal and Hepatic Disease
Chapter 35 Safe Medication Use. Drugs Commonly Used by Older Adults Cardiovascular agents Antihypertensives Analgesics Antiarthritic agents Sedatives.
Caring for Older Adults Holistically, 4th Edition Chapter Nineteen Pharmacology and Its Significance for Older Adults.
Polypharmacy and preventing hospital admissions
Clinical Pharmacy Part 2
Problems of Polypharmacy
Orientation to Pharmacology
Polypharmacy May 2008 CRIT Heidi Auerbach, MD Copyright Boston University Medical Center.
Bledsoe et al., Paramedic Care Principles & Practice Volume 1: Introduction © 2006 by Pearson Education, Inc. Upper Saddle River, NJ Basic Pharmacology.
Drug Therapy for Geriatric Clients Chapter 6. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Drug.
Age Changes By Sue Henderson.
Drug Therapy in the Elderly
Age Changes By Sue Henderson. Pharmacokinetics How body acts on drug: Reduced renal function, resulting in reduced elimination of renally excreted drugs.
Effects of Medication. Side Effects -- unintended or secondary effects 1. May not be harmful 2. May permit the drug to be used for a secondary purpose.
INTRODUCTION CLINICAL PHARMACOKINETICS
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 3 Life Span Considerations.
Impact of Multidisciplinary Team Care on Older People with Polypharmacy Liang-Kung Chen Center for Geriatrics and Gerontology Taipei Veterans General Hospital.
Chapter 6 Drug Therapy for Geriatric Clients Chapter 6.
PHT 415 BASIC PHARMACOKINETICS
Donepezil. Donepezil Generic name: Donepezil. Brand name: Aricept. Chemistry: Donepezil hydrochloride is a piperidine derivative. It is a white crystalline.
Foundation Knowledge and Skills
DOSAGE ADJUSTMENT IN RENAL AND HEPATIC DISEASES Course Title : Biopharmaceutics and Pharmacokinetics – II Course Teacher : Zara Sheikh.
종양혈액내과 R4 김태영 / prof. 정재헌. INTRODUCTION the most common, serious neuropsychiatric complication in cancer patients increased morbidity and mortality, hospitalization,
Medicines management in the elderly Trudi McIntosh and Kim Munro School of Pharmacy and Life Sciences RGU.
Drug efficacy is questioned.. Variation in drug responses.
Medication Management in the Older Patient. Older adults are more likely to have an Adverse Drug Reaction More likely to be on 5 or more medications Hazzard,
Copyright © 2016 by Elsevier, Inc. All rights reserved. Geropharmacology.
MCC - PI Guideline Pharmacological Action Pharmacodynamics –Describe mechanism of action (if known), pharmacodynamic effects, relevant clinical efficacy.
Management of Geriatric Psychiatric Disorders Arash Mirabzadeh Psychiatrist University of Social Welfare and Rehabilitation Sciences.
Meet & Greet. Welcome Objectives: 1. Review the core terminology used in pharmacology. 2. Discuss the features of the “perfect” drug. 3. Examine the.
Using an EHR Template and the Beer’s List to Address Geriatric Polypharmacy Rose Family Medicine Residency Emily Gutgsell, MD Emma Bjore, MD Anna Plunkett,
Drug Therapy in Geriatric Patients
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Pharmacokinetics and Factors of Individual Variation
CTD Module 4: Non-Clinical Studies SPC Relevant Scientific information
ROLE OF HEALTHCARE PROVIDER IN GERIATRIC COUNSELING
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Skills Workshop M1 Aging Week November 2012
Therapeutic Drug Monitoring chapter 1 part 1
Drug Therapy in Pediatric Patients
POLYPHARMACY.
Presentation transcript:

Pharmacology in the Elderly

Pharmacological Challenges in the Elderly  Pharmacokinetic changes  Pharmacodynamic changes  Multiple co-morbidities  Polypharmacy  More adverse effects  Adherence problems/cognition  Reduced diagnostic precision  Few well designed trials in this population

Pharmacokinetics in the Elderly  Absorption: remains relatively unchanged with age  Distribution: reduce in body water increase in body fat plasma protein binding  Metabolism: reduced hepatic blood flow reduced liver volume reduced enzymatic activity  Excretion: reduced renal blood flow atrophic renal tissue

Pharmacodynamic Changes  Changes in drug receptors/target organ responses - alter sensitivity to effect of drugs (> CNS effects of benzodiazepines) 2 nd to neuronal loss  Impairment of secondary compensatory mechanisms - predispose to adverse effects (orthostatic hypotension with diuretics or TCAs).

Co-morbidities  Lead to polypharmacy  Increased risk of developing adverse events 2 nd to co-morbidities  Risk of delirium 2 nd to anticholinergic drugs 2 nd to degeneration of cholinergic pathways  Increased risk of cerebrovascular events on some antipsychotics in people with pre- existing cerebrovascular damage (Shah and Shu, 2005)

Polypharmacy  Over age 65 people use an average of 8 drugs  1/3 of those has inappropriate use of at least one drug  10% are likely to have dangerous drug interaction (Cannon et al., 2006)

Minimising adverse effects  whenever possible, use non-pharmacological treatments  Start low, increase slowly, monitor frequently  smallest number of medications/simplest dose regimens  be familiar with drug effects in elderly  Alternative applications if difficulties swallowing tablets

Minimizing adverse events cont’d  Simple verbal/written instructions for every medication incl. generic/brand names, dosage, frequency, route and indication to avoid confusion  presenting symptoms may be a result of medications (not old age)  Avoid child-proof containers (also elder proof), use Webster pack or RDNS  Ensure carer understands treatment

Reference  Cannon, K.T., Choi, M.M., Zuniga, M.A. (2006), Potentially inappropriate use in elderly patients receiving home health care: a retrospective data analysis. American Journal of Geriatric Pharmacotherapy, 4(2),  Shah, A., Shu, G.H., (2005). A case for judicious use of risperidone and olanzapine in BPSD. International Psychogeriatrics, 17(1),